& Fibers GmbH, Germany (“IRFG”); and certain Intellectual Property Rights of INVISTA Textiles (U.K.) Limited with regards to its barrier technology. IVL would like to inform that all formalities with regards
, including the legal due diligence, use of the intellectual property in relation to the project and the execution of the shareholders agreement, provided however that the Transaction will be completed within
operating result – Relative to last year quarter’s, Loss Ratio had dropped by 8.64% (From 67.87% to 59.23%). Underwriting had been more selective. Sales associated with high risk clients had been monitored
) Derivatives, each coming with its own strong market position. The acquisition comes with its own strong R&D and technical capabilities apart from portfolio of about 900 patents and other intellectual properties
intellectual property, and utility assets. The Corpus Christi Project currently under development when completed will have nominal capacity of 1.1 million metric tons of PET and 1.3 million metric tons of PTA
Arteva Holdings GmbH; INVISTA Textiles (U.K.) Limited; and INVISTA Equities, LLC, to acquire a 100% stake in the PET business of INVISTA Resins & Fibers GmbH, Germany (“IRFG”); and certain Intellectual
been rendered by the Central Intellectual Property and International Trade Court, amounting 173 million Baht. However, the Company has a different view from the decision of the Court of First Instance in
and equipment and inventory), intellectual property, contracts and licenses in connection with and used for such business operation including all personnel related thereto, to in the Subsidiary
-year guidance, underpinned by improved 4G network and larger AIS Fibre coverage. QoQ, revenue slightly dropped by 0.8%. The handset campaigns were more selective, resulting in lower marketing expense
. Handset campaigns were more selective with limited discounts, resulting in marketing expenses subsiding from 10.5% to 6.3% to total revenue. Network OPEX rose 36% YoY mainly from fully recognized payment